In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adcock Ingram Pharmaceuticals

Division of Barlow Rand Ltd.

Latest From Adcock Ingram Pharmaceuticals

M&A Trends: Private Equity And 'Aspirational' Execs Pair Up In India

Private equity firms partnering with senior management professionals bitten by the entrepreneurial bug to buy pharmaceutical businesses in India were some of the emerging trends highlighted by experts at a recent CPhI congress in Mumbai. Scrip covers the key conference highlights on the "maturing" Indian M&A market, including how foreign firms are shedding their older portfolios to reallocate resources to newer products.

M & A India

Meiji snaps India's Medreich in face of 'Ranbaxy syndrome'

Japan's Meiji group has acquired the Indian contract development and manufacturing firm Medreich for $290m catapulting its plans to develop a competitive play in the generics business and expand in Asia and other emerging markets.

Spain Deals

Deal Watch: Shire Increases Rare Disease Holdings, Abbott Expands Latin American Interests

MedImmune and Bristol announce immuno-oncology combination trials with new partners on the same day, while AC Immune and Piramal Imaging will collaborate to develop an Alzheimer’s diagnostic to trace abnormal Tau protein in neuronal tissue.

BioPharmaceutical Deals

Abbott buys Chile's CFR Pharmaceuticals in $2.9bn deal

Abbott Laboratories has agreed to acquire the Chilean branded generics company CFR Pharmaceuticals for around $2.9bn. CFR's share price shot up 46% to CLP181.50 ($0.33) on the Santiago stock exchange in reaction to the news, which comes three months after CFR's own $1.3bn bid to buy the South African firm Adcock Ingram fell through in the face of local and shareholder opposition.

Peru
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Africa
      • South Africa
  • Parent & Subsidiaries
  • Barlow Rand Ltd.
  • Senior Management
  • Robbie Williams, Chmn.
    Manu Padiachy, Financial Manager
    Ted Shaw, National Accounts Executive
    Josh Fisher, PhD, Medical Director
  • Contact Info
  • Adcock Ingram Pharmaceuticals
    Phone: (27) 11315238
    209 15th Rd.
    Midrand, 1685
    South Africa
Advertisement
Advertisement
UsernamePublicRestriction

Register